Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases

Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases

US Patent 6849058 · Granted Feb 1, 2005

Estimated economic value: $13,791,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vision through photodynamic therapy of the eye2012
Method for reducing or preventing PDT related inflammation2012
Immuno-adjuvant PDT treatment of metastatic tumors2010
Photodynamic therapy in selective cell inactivation in blood and treating immune2009
Photodynamic therapy in selective cell inactivation in blood and treating immune2009
Ethylene glycol esters as photoactive agents2006
Treatment of macular edema2006
Ethylene glycol esters as photoactive agents2004
Methods, compositions and articles for reducing or preventing the effects of inf2004
Method to prevent xenograft transplant rejection2003
Treatment of macular edema2003
Vision through photodynamic therapy of the eye2003